Featured Suppliers:
Sponsored Links
NYSE Group Incorporated
News and Blogs
Total : 14 View more »
NYSE, New York Stock Exchange > About Us > News & Events > News Releases > Press Release 09-04-2009
www.nyse.com
cash products handled ADV in August 2009 increased 6.4% and 3.9% compared to August 2008 and July 2009, respectively, and increased 11.3% year-to-date.
http://www.nyse.com/press/1251972455747.html?sa_campaign=/rss/newsreleases/NYSE.comNewsReleases
NYSE Euronext Announces Trading Volumes for October 2009
www.nyse.com
November 6, 2009 – NYSE Euronext (NYX) today announced trading volumes for its global cash equities and derivatives exchanges for October 2009[1].
http://www.nyse.com/press/1257419178714.html?sa_campaign=/rss/newsreleases/NYSE.comNewsReleases
NYSE Group Inc. Issues Short Interest Report
www.nyse.com
New York, October 27, 2009 --The NYSE Group, Inc. today reported short interest as of the close of business on the settlement date of October 15, 2009.
http://www.nyse.com/press/1256639806827.html?sa_campaign=/rss/newsreleases/NYSE.comNewsReleases
NYSE Group Inc. Issues Short Interest Report
www.nyse.com
New York, October 09, 2009 --The NYSE Group, Inc. today reported short interest as of the close of business on the settlement date of September 30, 2009.
http://www.nyse.com/press/1255082641538.html?sa_campaign=/rss/newsreleases/NYSE.comNewsReleases
News from Zibb.com
Total : 3 View more »
NYSE Euronext Announces Trading Volumes for October 2009 - Zibb.com
Nov 06, 2009 (Hugin SAS via COMTEX) --
NYSE Euronext (NYX) today announced trading volumes for its global cash equities and derivatives exchanges for October 2009[1]. Trading volumes in October 2009 were mostly lower compared to October 2008 levels, during which crisis-level volatility drove record trading volumes. Trading volumes compared to September 2009 were mixed, with U.S. options and European cash increasing 6.3% and 7.1%, respectively, and European derivatives and U.S. cash decreasing, 11.1% and 3.3%, respectively.
Highlights NYSE Euronext European derivatives products average daily volume ("ADV") in October 2009 of 3.9 million contracts decreased 12.9% compared to October 2008, and decreased 11.1% from September 2009. Total interest rate products ADV in October 2009 of 2.0 million contracts decreased 9.5% compared to October 2008 and total equity products ADV of 1.8 million contracts decreased 16.9% compared to October 2008. NYSE Euronext U.S. equity options ADV of 3.2 million contracts in October 2009 increased 23.3% compared to October 2008 levels, and increased 6.3% from September 2009. NYSE Euronext's U.S. options exchanges accounted for 22.8% of the total consolidated equity options trading in October 2009, up from 17.6% in October 2008, and up from 21.4% in September 2009. NYSE Liffe U.S. futures and futures options ADV in October 2009 of approximately 22,000 contracts increased from approximately 21,000 contracts in September 2009 with the launch of equity index futures trading in September 2009 based on the MSCI U.S., EM and EAFE indexes. NYSE Euronext European cash products ADV of 1.6 million transactions in October 2009 decreased 26.1% compared to October 2008, but increased 7.1% from September 2009 and represented the third consecutive monthly increase in trading volumes since July with market share stable at approximately 78%. NYSE, NYSE Arca and NYSE Amex ("NYSE Group") U.S. cash products handled ADV of 2.9 billion shares in October 2009 decreased 38.9% compared to October 2008 and decreased 3.3% compared to September 2009. NYSE Group matched share of all U.S. equity trading volume in October 2009 was 28.1%, up from 28.0% in September 2009, and compared to matched market share of 24.7% for our next largest competitor. NYSE Group's Tape A matched market share in October 2009 was 36.6%, up from 36.1% in September 2009. NYSE Euronext is the largest exchange operator in the two fastest growing tapes in the U.S. equity markets. Year-to-date, total Tape A and Tape B consolidated ADV of 7.9 billion shares increased a combined 23.6%, compared to the prior year period, while Tape C consolidated ADV of 2.3 billion shares has declined 0.9% during the same period.
Derivatives Trading
European Derivatives NYSE Euronext European derivatives products ADV in October 2009 was 3.9 million futures and options contracts, a decrease of 12.9% from October 2008, and a decrease of 11.1% from the 4.4 million contracts recorded in September 2009. The 3.9 million in futures and options contracts ADV in October 2009 consisted of 3.3 million contracts executed through our full-service LIFFE CONNECT trading platform and 0.6 million, or 15.6%, executed through Bclear, NYSE Liffe's trade administration and clearing service for OTC products. Year-to-date European derivatives products ADV of 4.1 million contracts was 3.3% below prior year levels. Total interest rate products ADV of 2.0 million contracts in October 2009 decreased 9.5% and 12.7% from October 2008 and September 2009, respectively. Year-to-date, total interest rate products ADV decreased 12.4% compared to the prior year period. Total equity products (including Bclear) ADV of 1.8 million contracts in October 2009 decreased 16.9% compared to October 2008, and decreased 9.7% compared to September 2009. Year-to-date total equity products ADV increased 7.9% from the prior year period driven primarily by a 37.0% increase in volume executed through Bclear.
U.S. Derivatives NYSE Group U.S. equity options (NYSE Arca and NYSE Amex) ADV of 3.2 million contracts in October 2009 increased 23.3% compared to October 2008 and increased 6.3% compared to September 2009. The increase in ADV year-over-year and compared to September 2009 was driven in part by increased trading related to the anticipated sale of an equity stake in NYSE Amex Options and NYSE Amex Options pricing changes implemented July 1, 2009. Year-to-date, NYSE Group U.S. equity options volume of 2.6 million contracts was 47.5% above the prior year period driven in part by the addition of the former Amex options business. Total U.S. consolidated options ADV decreased 4.8% to 13.9 million contracts in October 2009, and was flat compared to September 2009. Year-to-date, U.S. consolidated options ADV of 13.6 million contracts was 0.7% above the prior year period. NYSE Euronext's U.S. options exchanges accounted for 22.8% of the total consolidated equity options trading in October 2009, up from 17.6% in October 2008, and up from 21.4% in September 2009. The increase in market share year-over-year and compared to September was driven in part by increased trading related to the anticipated sale of an equity stake in NYSE Amex Options and NYSE Amex Options pricing changes implemented July 1, 2009. NYSE Euronext U.S. futures and futures options (NYSE Liffe U.S.) ADV in October 2009 of approximately 22,000 contracts increased from approximately 21,000 contracts in September 2009 with the launch of equity index futures trading in September based on the MSCI U.S., EM and EAFE indexes.
Cash Trading
European Cash NYSE Euronext European cash products ADV of 1.6 million transactions in October 2009 decreased 26.1%, compared to October 2008, but increased 7.1% compared to September 2009 and represented the third consecutive monthly increase in ADV since July with market share stable at approximately 78%. Year-to-date, European cash products ADV of 1.4 million transactions was 12.0% below the same period last year.
U.S. Cash NYSE Group U.S. cash products handled ADV in October 2009 decreased 38.9% to 2.9 billion shares, compared to October 2008, and decreased 3.3% from September 2009. Year-to-date, NYSE Group handled ADV of 3.5 billion shares was 1.3% below the same period last year. NYSE Group matched share of all U.S. equity volume in October 2009 was 28.1%, compared to matched market share of 24.7% for our next largest competitor. Consolidated Tape A and Tape B trading volume in October 2009 accounted for approximately 75% of all Consolidated Tape trading in the U.S. market which includes trade reporting facility ("TRF") volumes.
NYSE-listed (Tape A) NYSE Group's Tape A matched market share in October 2009 was 36.6%, up from 36.1% in September 2009, and compared to matched market share of 19.5% for our next largest competitor. Tape A matched market share for NYSE was 25.1% in October 2009, above the 24.5% market share reported in October 2008. TRF market share across Tape A was 33.2%, down from 37.6% in August 2009, but up from 25.0% in December 2008. Designated Market Maker ("DMM") participation in October 2009 was 9.3%, compared to 9.1% in September 2009. Supplemental Liquidity Provider ("SLP") participation in October 2009 was 10.3%, compared to 9.5% in September 2009. A total of 7 SLPs are now on the platform. DMM and SLP participation pertain only to trading on NYSE.
NYSE Arca and NYSE Amex-listed (Tape B) Tape B matched market share of NYSE Group in October 2009 was 22.5%, down from 22.6% in September 2009, compared to matched market share of 27.3% for our nearest competitor. TRF market share across Tape B in October 2009 was 32.6% compared to 21.5% in December 2008.
Nasdaq-listed (Tape C) NYSE Group's Tape C matched market share in October 2009 increased to 12.3% from 12.2% in September 2009, compared to matched market share of 34.6% for our nearest competitor. TRF market share across Tape C in October 2009 was 38.9% compared to 29.9% in December 2008.
Exchange Traded Products NYSE Group matched exchange-traded products ADV (included in volumes from Tape B and Tape C noted above) of 346 million shares in October 2009 decreased 54.3% compared to October 2008, but increased 9.1% compared to September 2009. Year-to-date, matched exchange-traded products ADV was 11.5% above the prior year period.
Please click here for the Monthly Transaction Activity Data Table.
About NYSE Euronext NYSE Euronext (NYX) is a leading global operator of financial markets and provider of innovative trading technologies. The company's exchanges in Europe and the United States trade equities, futures, options, fixed-income and exchange-traded products. With more than 8,000 listed issues, NYSE Euronext's equities markets -- the New York Stock Exchange, Euronext, NYSE Arca and NYSE Amex -- represent nearly 40 percent of the world's equities trading, the most liquidity of any global exchange group. NYSE Euronext also operates NYSE Liffe, the leading European derivatives business and the world's second-largest derivatives business by value of trading. The company offers comprehensive commercial technology, connectivity and market data products and services through NYSE Technologies. NYSE Euronext is in the S&P 500 index, and is the only exchange operator in the S&P 100 index and Fortune 500. For more information, please visit: www.nyx.com
Cautionary Note Regarding Forward-Looking Statements
This press release may contain forward-looking statements, including forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements include, but are not limited to, statements concerning NYSE Euronext's plans, objectives, expectations and intentions and other statements that are not historical or current facts. Forward-looking statements are based on NYSE Euronext's current expectations and involve risks and uncertainties that could cause actual results to differ materially from those expressed or implied in such forward-looking statements. Factors that could cause NYSE Euronext's results to differ materially from current expectations include, but are not limited to: NYSE Euronext's ability to implement its strategic initiatives, economic, political and market conditions and fluctuations, government and industry regulation, interest rate risk and U.S. and global competition, and other factors detailed in NYSE Euronext's reference document for 2008 ("document de référence") filed with the French Autorité des Marchés Financiers (Registered on April 28, 2009 under No. R. 09-031), 2008 Annual Report on Form 10-K and other periodic reports filed with the U.S. Securities and Exchange Commission or the French Autorité des Marchés Financiers. In addition, these statements are based on a number of assumptions that are subject to change. Accordingly, actual results may be materially higher or lower than those projected. The inclusion of such projections herein should not be regarded as a representation by NYSE Euronext that the projections will prove to be correct. This press release speaks only as of this date. NYSE Euronext disclaims any duty to update the information herein.
[1] Euronext equities transactions count each buy and sell order as separate transactions, NYSE Group equities transactions count buy and sell orders together as a single transaction. All NYSE Euronext derivatives transactions count buy and sell orders together as a single transaction.
Copyright Hugin
The appendixes relating to the press release are available on: http://www.hugingroup.com/documents_ir/PJ/CO/2009/160123_88_JOEQ_NYX-PR-October2009-Volumes.pdf http://www.hugingroup.com/documents_ir/PJ/CO/2009/160123_66_C2XJ_NYX-Transactions-Data-October09.pdf
Information réglementée : Type : Nouvelle information Thème(s): Communiqués au titre de l'obligation d'information permanente - Autres communiqués
This announcement is originally distributed by Hugin. The issuer is solely responsible for the content of this announcement.
[CN#160123]
Tags: amex annual report business commercial equity europe futures government index liffe market market share nasdaq note nyse otc products securities technology trade
Companies: NYSE Group Inc (NYX)
NYSE Euronext Announces Third Quarter 2009 Financial Results - Zibb.com
NEW YORK, Oct 30, 2009 (BUSINESS WIRE) --
-- Announces Equity Investment by Leading Liquidity Providers in its U.S. Futures Exchange --
--Conference Call, Friday, October 30, 2009 at 8:00 a.m. (New York, EDT)/1:00 p.m. (Paris, CET)
NYSE Euronext (NYX) today reported net income of $125 million, or $0.48 per diluted share, for the third quarter of 2009, compared to net income of $174 million, or $0.66 per diluted share for the third quarter of 2008. Third quarter 2009 GAAP results include the impact from merger expenses and exit costs, the impact of the disposition of Hugin Group B.V., the sale of our investment in BM&F Bovespa and a fair value adjustment to our investment in BIDS Holdings, L.P. Pro forma non-GAAP diluted earnings per share excluding these items was $0.53 in the third quarter of 2009, compared to $0.72 in the third quarter of 2008.
"We continue to see stabilization in our core businesses and significant progress on our new initiatives," said Duncan L. Niederauer, CEO, NYSE Euronext. "We have successfully maintained market share in our U.S. (NYSE) and European cash markets and have grown market share in U.S. equity options. We have seen a strong increase in new issuances, where we lead the U.S. in both IPOs and secondaries. We significantly enhanced our global derivatives franchise with today's announced semi-mutualization of our U.S. futures exchange. In addition, we announced a similar semi-mutualization of our NYSE Amex equity options business, launched NYSE Liffe Clearing in Europe and established New York Portfolio Clearing, a joint venture with DTCC. Lastly, our announced acquisition of NYFIX will greatly expand our NYSE Technologies product offering and client base."
The table below summarizes our pro forma non-GAAP results:
($ in millions, except EPS) 3Q09 2Q09 3Q08 Gross Revenues $1,048 $1,125 $1,159 Net Revenues $624 $611 $724 Fixed Operating Expenses ($431) ($398) ($428) Operating Income(1) $197 $214 $297 Net Income $138 $132 $192 Diluted Earnings Per Share $0.53 $0.51 $0.72 (1) Includes regulatory fine income
Michael S. Geltzeiler, Group Executive Vice President and Chief Financial Officer, NYSE Euronext, commented, "Despite lower overall trading volumes, the contribution of NYSE Liffe Clearing revenue during the quarter drove higher net revenues and earnings per share compared to the second quarter. Additionally, we continue to focus on initiatives to reduce our fixed cost base. Underlying fixed operating expenses through the third quarter, excluding the impact of M&A, foreign exchange fluctuations and investments in new businesses, were down $121 million, or 10% compared to the same period last year. With the anniversary of the Amex acquisition, we expect our fourth quarter fixed operating expenses to be considerably below prior year levels and will end the year below our full-year 2009 fixed cost guidance of $1,728 million."
Pro forma non-GAAP net income for the third quarter of 2009 was $138 million, or $0.53 per diluted share, compared to net income of $192 million, or $0.72 per diluted share, for the third quarter of 2008. Pro forma non-GAAP results for the third quarter of 2009 exclude $8 million in merger expenses and exit costs. The results also exclude the impact of the disposition of Hugin Group B.V., the sale of our investment in BM&F Bovespa and a fair value adjustment to our investment in BIDS Holdings, L.P. Pro forma non-GAAP results for the third quarter of 2008 exclude $30 million in pre-tax merger expenses and exit costs, primarily severance. In addition, pro forma non-GAAP results also exclude activity assessment and Section 31 fees(1). A full reconciliation of our pro forma non-GAAP results is included in the attached tables.
Financial highlights on a pro forma non-GAAP basis include:
-- Gross revenues, excluding activity assessment fees, were $1,048 million in the third quarter of 2009, a 10% decrease compared to the third quarter of 2008 and a 7% decrease compared to the second quarter of 2009. Third quarter 2009 gross revenues compared to both the third quarter of 2008 and the second quarter of 2009 were negatively impacted by a decline in global cash equities volumes and pricing changes across our European and U.S. cash businesses.
-- Net revenues, defined as gross revenues less direct transaction costs consisting of Section 31 fees, liquidity payments and routing and clearing fees, were $624 million, down 14% compared to $724 million in the third quarter of 2008, but up 2% compared to the $611 million in the second quarter of 2009. Third quarter 2009 net revenues compared to the third quarter of 2008 include a $30 million negative impact attributable to foreign currency fluctuations. NYSE Euronext net revenues from its primary business activities are represented below as a percentage of total net revenues for the third quarter: -- Global derivatives trading accounts for 30%
-- European cash trading accounts for 13%
-- U.S. cash trading accounts for 9%
-- Global market data accounts for 16%
-- Global listings accounts for 16%
-- Software and technology services accounts for 8%
-- Other accounts for 8%
-- Fixed operating expenses, defined as operating expenses less merger expenses and exit costs, direct transaction costs, and excluding regulatory fine income, were $431 million, compared to $428 million in the third quarter of 2008 and $398 million in the second quarter of 2009. Excluding the impact of mergers and acquisitions, foreign exchange rates and investment in new businesses, underlying fixed expenses were down $31 million, or 7% compared to the third quarter of 2008. Fixed costs increased $33 million compared to the second quarter of 2009, primarily due to a benefits' curtailment gain of $10 million in the second quarter of 2009 and a combined $20 million in NYSE Liffe Clearing expenses and foreign currency fluctuations. Underlying fixed expenses through the first nine months of 2009 were down $121 million or 10% compared to the prior year period.
-- Operating income was $197 million, down $100 million compared to the third quarter of 2008 and down $17 million compared to the second quarter of 2009. Third quarter 2009 operating income compared to the third quarter of 2008 includes a $20 million negative impact attributable to foreign currency fluctuations.
-- At September 30, 2009, net debt was $2.4 billion. Cash, cash equivalents, investments and other securities (including $115 million related to Section 31 fees collected from market participants and due to the SEC) was $0.5 billion and total debt was $2.9 billion. Total debt of $2.9 billion, consists of $2.2 billion in long-term debt and $0.7 billion in short-term debt. The increase in short-term debt from the second quarter of 2009 was due to the issuance of commercial paper associated with the $355 million termination payment made to LCH.Clearnet to facilitate the in-sourcing of clearing activities for NYSE Liffe Clearing.
-- Pro-forma non-GAAP third quarter results include the favorable impact of an effective tax rate true-up for fiscal 2009 from 29% to 27% as a result of the mix of profits from our global subsidiaries, which added $0.03 to third quarter 2009 diluted earnings per share.
-- Headcount as of September 30, 2009 was 3,399, down 4% from June 30, 2009 and down 10% from December 31, 2008.
Market and Business Summary
Global Derivatives Markets
-- Global Derivatives net revenue, which includes our European and U.S. derivatives businesses, was $184 million in the third quarter of 2009, up 4% from $177 million in the third quarter of 2008 and up 17% from $157 million recorded in the second quarter of 2009. The increase in net revenue in the third quarter of 2009 compared to the third quarter of 2008 was driven by the addition of NYSE Liffe Clearing, which launched July 30, 2009 and NYSE Amex options, which was acquired on October 1, 2008. The increase compared to the second quarter of 2009 was driven by the addition of NYSE Liffe Clearing.
European Derivatives
-- European Derivatives net revenue of $152 million in the third quarter of 2009 decreased 2% from the $155 million in the third quarter of 2008, but was up $28 million, or 23% from the $124 million posted in the second quarter of 2009. The increase in net revenue from the second quarter of 2009 was driven by the addition of clearing fees from NYSE Liffe Clearing for two months.
-- For the third quarter of 2009, European derivatives products average daily volume ("ADV") was 3.8 million contracts, 1.4% above the 3.8 million contracts recorded in the third quarter of 2008. The 3.8 million in futures and options contracts ADV in the third quarter of 2009 consisted of 2.9 million contracts executed through our full-service LIFFE CONNECT trading platform and a total of 0.9 million contracts processed through Bclear, NYSE Liffe's trade administration and clearing service for OTC products. This compares to 3.1 million contracts executed through LIFFE CONNECT and 0.6 million contracts processed through Bclear in the third quarter of 2008. Fees related to Bclear are significantly lower than our other European derivatives products traded through our full-service offering, LIFFE CONNECT, and include fee caps. Year-to-date European derivatives products ADV of 4.1 million contracts was 2.1% below prior year levels.
-- Total interest rate products ADV for the third quarter of 2009 of 1.9 million contracts was down 0.7% compared to the third quarter of 2008. Year-to-date, total interest rate products ADV decreased 12.8% compared to the prior year period.
-- Total equity products (including Bclear) ADV of 1.9 million contracts in the third quarter of 2009 was 3.8% above the third quarter of 2008. Year-to-date, total equity products ADV increased 11.3% compared to the prior year period.
U.S. Derivatives
-- U.S. Derivatives net revenue of $32 million in the third quarter of 2009, increased $10 million from the third quarter of 2008, but decreased $1 million from the second quarter of 2009. The increase in net revenue when compared to the third quarter of 2008 was driven primarily by the addition of the former Amex options business which closed on October 1, 2008.
-- In the third quarter of 2009, U.S. equity options ADV was 2.6 million contracts, a 46.3% increase compared to the third quarter of 2008, which did not include trading activity from the former Amex options business acquired in the fourth quarter of 2008. U.S. equity options market share in the third quarter of 2009 was 19.5%, up from 12.3% in the third quarter of 2008 and up from 18.2% in the second quarter of 2009. Overall U.S. equity options industry ADV decreased 8.1% compared to the third quarter of 2008 and was down slightly from the second quarter of 2009. Year-to-date, NYSE Group U.S. equity options ADV of 2.5 million contracts was 43.1% above the prior year period.
-- NYSE Euronext agreed in principle on a framework with leading liquidity providers and market making firms BofA Merrill Lynch, Barclays Capital, Citadel Securities, Citi, Goldman Sachs, TD AMERITRADE and UBS, to sell a significant equity interest in NYSE Amex options, one of the company's two U.S. options exchanges. Under the new framework, NYSE Euronext will remain the largest shareholder in the entity, which aims to enhance the competitive position of NYSE Amex options, while bringing competitive and operational benefits to the marketplace. The contemplated transaction calls for NYSE Euronext to continue to manage the day-to-day operations of NYSE Amex options, which would operate under the supervision of a separate board of directors and a dedicated chief executive officer. NYSE Euronext will continue to consolidate the financial reporting of this entity.
-- Effective July 1, 2009 NYSE Arca options and NYSE Amex options eliminated Firm Facilitation Fees to firms who facilitate their customer order flow. The Firm Facilitation Fee applies to any transaction involving a firm's proprietary trading account, which has a customer of that same firm on the contra side of the transaction. Both exchanges also lowered the Broker Dealer/Firm Manual Fee. The resulting incremental increase in order flow and market share for NYSE Amex options offset this pricing reduction.
-- NYSE Liffe U.S. futures and futures options ADV in the third quarter of 2009 was 15 thousand contracts, for a total of 950 thousand contracts traded during the quarter. Year-to-date, a total of 3.1 million contracts have been traded. Beginning September 8, 2009 NYSE Liffe U.S. futures and futures options ADV includes equity index futures trading based on the MSCI U.S., EM and EAFE indexes. Market share for the MSCI indexes in the first month of trading was 19.0%.
-- NYSE Euronext announced the signing of a binding agreement with several leading global banks and liquidity providers -- Citadel Securities, GETCO, Goldman Sachs, Morgan Stanley and UBS -- on transaction terms to sell a significant equity interest in NYSE Liffe U.S. NYSE Euronext will remain the largest shareholder in the entity, which will bring substantial competitive and operational benefits to the marketplace. NYSE Euronext will continue to manage the day-to-day operations of NYSE Liffe U.S., which will operate under the supervision of a separate Board of Directors, chaired by Jim McNulty, and Chief Executive Officer Thomas F. Callahan. The transaction is expected to close shortly subject to regulatory review.
-- NYSE Euronext and The Depository Trust & Clearing Corporation (DTCC) finalized their formal agreement to create their innovative new joint venture, New York Portfolio Clearing (NYPC). NYPC expects to be operational in the second quarter of 2010, pending CFTC and SEC approval.
Global Cash Markets
-- Global cash markets net revenue, which includes our U.S. and European cash equities businesses, was $135 million in the third quarter of 2009, down 46% from the third quarter of 2008 and down 11% from the second quarter of 2009. The decrease in net revenue compared to the third quarter of 2008 and second quarter of 2009 was driven primarily by declines in global cash trading volumes and net pricing reductions.
U.S. Cash Equities
-- U.S. cash equities net revenue of $54 million in the third quarter of 2009, decreased $35 million from the third quarter of 2008 and decreased $14 million from the second quarter of 2009. The decrease in net revenue for both periods was driven primarily by declines in trading volumes and net pricing reductions.
-- In the third quarter of 2009, NYSE Group handled ADV of 2.9 billion shares across all U.S. equity markets was 19.2% below the third quarter of 2008, and 19.7% below the second quarter of 2009. Year-to-date, NYSE Group handled ADV of 3.5 billion shares was 5.2% above the same period last year. NYSE Group matched share of all U.S. equity markets volume in the third quarter was 27.9%, compared to 22.0% for our next largest competitor. NYSE-listed (Tape A) matched market share in the third quarter of 2009 was 35.4%, compared to 39.3% in the second quarter of 2009. NYSE Tape A matched market share in September 2009 was 25.0%, above the 24.1% matched market share recorded in September 2008. NYSE-listed (Tape A) matched market share for our next largest competitor in the third quarter of 2009 was 17.1%. The decline in market share in the third quarter of 2009 was driven in part by a significant increase in the top-10 most actively traded stocks which represented approximately 32% of Tape A consolidated activity during the quarter, up from approximately 26% in the second quarter of 2009.
-- The organic liquidity of NYSE was significantly enhanced in the third quarter of 2009 with the addition of several Supplemental Liquidity Providers ("SLPs"). There are now a total of seven SLPs on NYSE, including Citadel Derivatives Group, LLC, Goldman Sachs & Co., Knight Equity Markets L.P., Merrill Lynch Pierce Fenner & Smith, OCTEG, LLC and Spear, Leeds & Kellogg Specialists, LLC. With the expansion of the SLP group, SLP participation has increased from 7.5% in June 2009 to 9.5% in September 2009.
European Cash Equities
-- European cash equities net revenue of $81 million in the third quarter of 2009, decreased $80 million from the third quarter of 2008 and decreased $3 million from the second quarter of 2009. The decrease in net revenue compared to the third quarter of 2008 was driven by a 15% drop in trading volumes as well as a decline in pricing. The decrease in net revenue versus the second quarter of 2009 was due to lower trading volumes and a pricing change effective September 1, 2009.
-- In the third quarter of 2009, ADV of 1.3 million transactions was 15.0% below the third quarter of 2008 and 9.4% below the second quarter of 2009. Year-to-date ADV of 1.4 million transactions was 9.5% below the same period last year.
-- Market share in terms of value traded for our regulated markets increased slightly to 77% in the third quarter of 2009.
Exchange Traded Products and Global Indexes
-- In the third quarter of 2009, NYSE Group matched exchange-traded funds ("ETF") ADV (included in U.S. cash equities trading volumes above) of 335 million shares decreased 29.3%, compared to the third quarter of 2008, and decreased 35.9% compared to the second quarter of 2009. In the third quarter, NYSE Group matched volume for ETFs represented 13% of all matched volumes traded by NYSE Group. Year-to-date, matched ETF ADV was 27.2% above the prior year period. The third quarter of 2008 did not include the former Amex ETF business.
-- In the third quarter of 2009, consolidated Exchange Traded Products U.S. dollar volume traded represented approximately 29% of all consolidated U.S. dollar volume traded.
-- As of the third quarter of 2009, NYSE Euronext had over 740 index licenses outstanding for various exchange traded index tracking products, compared to approximately 567 index licenses outstanding as of the third quarter of 2008.
Global Listings
-- Total global listings revenue in the third quarter of 2009 was $100 million, compared to $98 million in the third quarter of 2008 and $101 million in the second quarter of 2009.
-- In the third quarter of 2009, a total of 11 IPOs listed on NYSE Euronext markets for total proceeds of $3.5 billion. Among the IPOs were 2 closed-end funds, 5 REITs and 3 operating companies including Emdeon, Inc., Artio Global Investors, Inc. and Select Medical Holdings Corporation, as well as 1 IPO on NYSE Euronext's European markets.
-- Through September 30, 2009, there were a total of 353 global IPOs that raised $55.7 billion, down from 801 IPOs that raised $109.4 billion globally in the same period last year. According to Dealogic, year-to-date through October 28, NYSE Euronext raised the second most capital through 37 IPOs for a total of $16.3 billion, behind the Hong Kong Stock Exchange which raised a total of $16.8 billion, but ahead of the Shanghai Exchange that raised $14.5 billion, and Nasdaq OMX which raised $7.4 billion through 23 IPOs.
-- Juniper Networks, Inc., the leader in high-performance networking, transferred its listing from NASDAQ to the NYSE and began trading on October 29, 2009, retaining its symbol "JNPR".
-- Banco Santander (Brasil) S.A., one of Brazil's leading banks, began trading on the NYSE under the ticker symbol "BSBR" after its successful initial public offering in which it raised $7.0 billion (excluding over-allotments). The Banco Santander (Brasil) IPO, which listed simultaneously in Brazil and the U.S., is the largest initial public offering ever conducted by a Brazilian company.
-- Red Hat, Inc. became the newest NYSE-listed component of the S&P 500. A total of 411 NYSE-listed companies represent over 82% of the S&P 500. As of September 30, 2009, the total global market capitalization of NYSE-listed technology, media and telecommunications companies was $2.5 trillion.
-- NYSE Euronext closed its transaction with Thomson Reuters to sell Hugin Group B.V. on October 14. As part of the agreement, Thomson Reuters and NYSE Euronext will expand their strategic partnership in offering value-added services to the issuer community.
Technology Services
-- NYSE Euronext entered into a definitive agreement to acquire NYFIX, Inc., a leading provider of innovative solutions that optimize trading efficiency for $144 million, including preferred stock consideration. The transaction is expected to close in the fourth quarter of 2009 and to be accretive to NYSE Euronext 2010 earnings, excluding one-time deal and restructuring costs. The NYFIX Marketplace is one of the industry's broadest and deepest FIX-based communities where more than 1,000 global trading counterparties connect to one another via more than 9,000 fully managed FIX-based messaging channels.
-- Tokyo Stock Exchange, Inc. successfully launched its "Tdex+ System," a new trading platform for options contracts. Tdex+ System is the advanced electronic trading system based on LIFFE CONNECT(R), used by NYSE Liffe.
-- NYSE Technologies plans to expand the services of its Secure Financial Transaction Infrastructure(R) (SFTI(R)) to Asia providing market participants with improved connectivity to NYSE Liffe. SFTI(R) provides a single point of connectivity with lowest-latency access to multiple markets. It is one of the industry's most secure and resilient platforms, specifically built for electronic trading and market data traffic. SFTI(R) reduces the cost and risk associated with connecting and managing multiple third-party networks. It enables firms to reduce their time-to-market, improve their performance and significantly lower the cost of their trading infrastructure.
-- NYSE Technologies will collaborate with Standard Chartered PLC, a banking leader in Asia, Africa and the Middle East, to develop sophisticated FX trading analysis capabilities using the OneTick(TM) tick capture and time-series analysis application.
-- AboveNet, Inc., a leading provider of high-bandwidth connectivity solutions, announced that it is working with NYSE Euronext to build fiber optic networks connecting NYSE Euronext's new data centers being built in the greater New York and London metropolitan areas.
Analyst/Investor/Media Call: October 30, 2009 at 8:00 a.m. (NY/EDT)/1:00 p.m. (Paris/CET)
A presentation and live audio webcast of the third quarter 2009 earnings conference call will be available on the Investor Relations section of NYSE Euronext's website, http://www.nyseeuronext.com/ir. Those wishing to listen to the live conference via telephone should dial-in at least ten minutes before the call begins. An audio replay of the conference call will be available approximately one hour after the call on the Investor Relations section of NYSE Euronext's website, http://www.nyseeuronext.com/ir or by dial-in beginning approximately two hours following the conclusion of the live call.
Live Dial-in Information: United States: 800.706.7745 International: 617.614.3472 Passcode: 26616734 Replay Dial-in Information: United States: 888.286.8010 International: 617.801.6888 Passcode: 34538720
To supplement NYSE Euronext's consolidated financial statements prepared in accordance with GAAP and to better reflect period-over-period comparisons, NYSE Euronext uses non-GAAP financial measures of performance, financial position, or cash flows that either exclude or include amounts that are not normally excluded or included in the most directly comparable measure, calculated and presented in accordance with GAAP. Non-GAAP financial measures do not replace and are not superior to the presentation of GAAP financial results, but are provided to (i) present the effects of certain merger expenses, exit costs and other non-recurring items, and (ii) improve overall understanding of NYSE Euronext's current financial performance and its prospects for the future. Specifically, NYSE Euronext believes the non-GAAP financial results provide useful information to both management and investors regarding certain additional financial and business trends relating to financial condition and operating results. In addition, management uses these measures for reviewing financial results and evaluating financial performance. The non-GAAP adjustments for all periods presented are based upon information and assumptions available as of the date of this release.
NYSE Euronext Earnings News Release with Tables and Operating Data
About NYSE Euronext
NYSE Euronext (NYX) is a leading global operator of financial markets and provider of innovative trading technologies. The company's exchanges in Europe and the United States trade equities, futures, options, fixed-income and exchange-traded products. With more than 8,000 listed issues, NYSE Euronext's equities markets -- the New York Stock Exchange, NYSE Euronext, NYSE Amex and NYSE Alternext as well as NYSE Arca -- represent nearly 40 percent of the world's equities trading, the most liquidity of any global exchange group. NYSE Euronext also operates NYSE Liffe, the leading European derivatives business and the world's second-largest derivatives business by value of trading. The company offers comprehensive commercial technology, connectivity and market data products and services through NYSE Technologies. NYSE Euronext is in the S&P 500 index, and is the only exchange operator in the S&P 100 index and Fortune 500. For more information, please visit: http://www.nyx.com
Cautionary Note Regarding Forward-Looking Statements
This press release may contain forward-looking statements, including forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements include, but are not limited to, statements concerning NYSE Euronext's plans, objectives, expectations and intentions and other statements that are not historical or current facts. Forward-looking statements are based on NYSE Euronext's current expectations and involve risks and uncertainties that could cause actual results to differ materially from those expressed or implied in such forward-looking statements. Factors that could cause NYSE Euronext's results to differ materially from current expectations include, but are not limited to: NYSE Euronext's ability to implement its strategic initiatives, economic, political and market conditions and fluctuations, government and industry regulation, interest rate risk and U.S. and global competition, and other factors detailed in NYSE Euronext's reference document for 2008 ("document de reference") filed with the French Autorite des Marches Financiers (Registered on April 28, 2009 under No. R. 09-031), 2008 Annual Report on Form 10-K and other periodic reports filed with the U.S. Securities and Exchange Commission or the French Autorite des Marches Financiers. In addition, these statements are based on a number of assumptions that are subject to change. Accordingly, actual results may be materially higher or lower than those projected. The inclusion of such projections herein should not be regarded as a representation by NYSE Euronext that the projections will prove to be correct. This press release speaks only as of this date. NYSE Euronext disclaims any duty to update the information herein.
(1) Section 31 of the Securities Exchange Act of 1934 requires each Self-Regulatory Organization to pay the SEC twice annually a fee based on the aggregate dollar amount of certain sales of securities such that the SEC can recover the costs to the government of supervision and regulation of securities markets and securities professionals.
NYSE Euronext
Condensed consolidated statements of income in accordance with U.S.
GAAP (unaudited)
(in millions, except per share data)
Threemonths ended September30, Ninemonths ended September30,
2009 2008 2009 2008
Revenues
Activity assessment $ 115 $ 46 $ 271 $ 189
Cash trading 516 634 1,751 1,708
Derivatives trading and clearing 226 229 620 729
Listing 100 98 300 294
Market data 102 112 305 321
Software and technology services 52 47 140 107
Regulatory 9 8 31 36
Other 43 31 138 102
Total revenues 1,163 1,205 3,556 3,486
Section 31 fees (115 ) (46 ) (271 ) (189 )
Liquidity payments (363 ) (358 ) (1,242 ) (887 )
Routing and clearing (61 ) (77 ) (204 ) (211 )
Merger expenses and exit costs (8 ) (30 ) (473 ) (83 )
Compensation (166 ) (168 ) (492 ) (480 )
Systems and communications (54 ) (66 ) (167 ) (237 )
Professional services (65 ) (44 ) (163 ) (106 )
Depreciation and amortization (66 ) (65 ) (200 ) (181 )
Occupancy (39 ) (37 ) (113 ) (96 )
Marketing and other (41 ) (48 ) (116 ) (133 )
Regulatory fine income 4 1 5 3
Operating income from continuing operations 189 267 120 886
Net interest and investment loss (28 ) (31 ) (81 ) (72 )
Gain on sale of equity investment - - - 2
Other income 10 5 19 28
Income from continuing operations before income tax provision 171 241 58 844
Income tax provision (47 ) (70 ) (7 ) (244 )
Income from continuing operations 124 171 51 600
Income from discontinued operations, net of tax - 3 - 5
Net income 124 174 51 605
Net income attributable to noncontrolling interest 1 - (4 ) (5 )
Net income attributable to NYSE Euronext $ 125 $ 174 $ 47 $ 600
Basic earnings per share from continuing operations $ 0.48 $ 0.65 $ 0.18 $ 2.24
Basic earnings per share from discontinued operations - 0.01 - 0.02
Basic earnings attributable to NYSE Euronext per share $ 0.48 $ 0.66 $ 0.18 $ 2.26
Diluted earnings per share from continuing operations 0.48 $ 0.65 $ 0.18 $ 2.24
Diluted earnings per share from discontinued operations - 0.01 - 0.02
Diluted earnings attributable to NYSE Euronext per share $ 0.48 $ 0.66 $ 0.18 $ 2.26
Basic weighted average shares outstanding 260 266 260 266
Diluted weighted average shares outstanding 261 266 260 266
NYSE Euronext
Condensed combined statements of income including
non-GAAP financial measures (unaudited)
(in millions, except
per share data)
We use non-GAAP financial measures of operating performance.
Non-GAAP measures do not replace and are not superior to the
presentation of our GAAP financial results but are provided to
improve overall understanding of our current financial performance
and our prospects for the future.
Please refer to the table entitled "Reconciliation of non-GAAP
Financial Measures to GAAP Measures (unaudited)"
Three months ended September 30, [a, b, c, d] Nine months ended September 30, [a, b, c, d]
2009 2008 2009 2008
Pro Forma Pro Forma Pro Forma Pro Forma
Combined Combined Combined Combined
Revenues
Cash trading $ 516 $ 634 $ 1,751 $ 1,708
Derivatives trading and clearing 226 229 620 729
Listing 100 98 300 294
Market data 102 112 305 321
Software and technology services 52 47 140 107
Regulatory 9 8 31 36
Other 43 31 138 102
Total revenues 1,048 1,159 3,285 3,297
Liquidity payments (363 ) (358 ) (1,242 ) (887 )
Routing and clearing (61 ) (77 ) (204 ) (211 )
Compensation (166 ) (168 ) (492 ) [f] (516 ) [e]
Systems and communications (54 ) (66 ) (167 ) (237 )
Professional services (65 ) (44 ) (163 ) (106 )
Depreciation and amortization (66 ) (65 ) (200 ) (181 )
Occupancy (39 ) (37 ) (113 ) (96 )
Marketing and other (41 ) (48 ) (116 ) (133 )
Regulatory fine income 4 1 5 3
Operating income 197 297 593 933
Net interest and investment loss (28 ) (31 ) (81 ) (72 )
Other income 6 [g] 5 15 [g] 28
Income before income tax provision 175 271 527 889
Income tax provision (38 ) (79 ) (141 ) (258 )
Net income 137 192 386 631
Net income attributable to noncontrolling interest 1 - (4 ) (5 )
Net income attributable to NYSE Euronext $ 138 $ 192 $ 382 $ 626
Basic earnings per share $ 0.53 $ 0.72 $ 1.47 $ 2.36
Diluted earnings per share $ 0.53 $ 0.72 $ 1.47 $ 2.36
Basic weighted average shares outstanding 260 266 260 266
Diluted weighted average shares outstanding 261 266 260 266
The pro forma non-GAAP results of NYSE Euronext include the
following adjustments to the GAAP results:
[a] The results of operations are presented as if the divestiture of
the investment in GL Trade had been completed at the beginning of
the earliest period presented.
[b] Merger expenses and exit costs of $8 million and $30 million have
been eliminated from the results of operations for the three
months ended September 30, 2009 and 2008, respectively, and $473
million and $83 million for the nine months ended September 30,
2009 and 2008, respectively, as they represent non-recurring
charges.
[c] Activity assessment fees and Section 31 fees have been excluded
from revenues and expenses, respectively, as they have no impact
on operating income or net income.
[d] Gains on sale of equity investments of $0 million and $2 million
have been eliminated from the results of operations for the three
and nine months ended September 30, 2008, respectively, as they
represent non-recurring items.
[e] Excludes $36 million of income from the reversal of an accrual
relating to certain litigation between a former Chairman & CEO and
the NYSE, which was terminated on July 31, 2008.
[f] Includes a $10 million curtailment gain associated with a change in
our retiree medical plan.
[g] Excludes a $4 million net gain from the sale of our investment in
BM&F Bovespa, partially offset by fair value adjustments of our
investments in Hugin, an asset-held-for-sale, and BIDS Holdings,
L.P.
NYSE Euronext
Condensed combined statements of income including
non-GAAP financial measures (unaudited)
(in millions, except
per share data)
We use non-GAAP financial measures of operating performance.
Non-GAAP measures do not replace and are not superior to the
presentation of our GAAP financial results but are provided to
improve overall understanding of our current financial performance
and our prospects for the future.
Three months ended Three months ended
September 30, 2009 [a, b, c] September 30, 2008 [a, b, c]
US European Corporate Pro Forma US European Corporate Pro Forma
Operations Operations Items [e] Combined Operations Operations Items [e] Combined
Revenues
Cash trading $ 435 $ 81 $ - $ 516 $ 473 $ 161 $ - $ 634
Derivatives trading and clearing 46 180 - 226 39 190 - 229
Listing 91 9 - 100 90 8 - 98
Market data 54 48 - 102 52 60 - 112
Other revenues 63 47 (6 ) 104 64 22 - 86
Total revenues (1) 689 365 (6 ) 1,048 718 441 - 1,159
Liquidity payments, routing and clearing (2) (396 ) (28 ) - (424 ) (401 ) (34 ) - (435 )
Fixed operating expenses (243 ) (188 ) - (431 ) (221 ) (199 ) (8 ) (428 )
Regulatory fine income 4 - - 4 1 - - 1
Operating income $ 54 $ 149 $ (6 ) $ 197 $ 97 $ 208 $ (8 ) $ 297
Net revenues= (1) + (2) $ 293 $ 337 $ (6 ) $ 624 $ 317 $ 407 $ - $ 724
Nine months ended Nine months ended
September 30, 2009 [a, b, c] September 30, 2008 [a, b, c]
US European Corporate Pro Forma US European Corporate Pro Forma
Operations Operations Items [e] Combined Operations Operations Items [e] Combined
Revenues
Cash trading $ 1,483 $ 268 $ - $ 1,751 $ 1,222 $ 486 $ - $ 1,708
Derivatives trading and clearing 136 484 - 620 108 621 - 729
Listing 273 27 - 300 269 25 - 294
Market data 165 140 - 305 156 165 - 321
Other revenues 189 146 (26 ) 309 192 53 - 245
Total revenues (1) 2,246 1,065 (26 ) 3,285 1,947 1,350 - 3,297
Liquidity payments, routing and clearing (2) (1,351 ) (96 ) 1 (1,446 ) (978 ) (120 ) - (1,098 )
Fixed operating expenses (717 ) (542 ) 8 (1,251 ) (661 ) [d] (573 ) (35 ) (1,269 )
Regulatory fine income 5 - - 5 3 - - 3
Operating income $ 183 $ 427 $ (17 ) $ 593 $ 311 $ 657 $ (35 ) $ 933
Net revenues= (1) + (2) $ 895 $ 969 $ (25 ) $ 1,839 $ 969 $ 1,230 $ - $ 2,199
The pro forma non-GAAP results of NYSE Euronext include the
following adjustments to the GAAP results:
[a] The results of operations are presented as if the divestiture of the
investment in GL Trade had been completed at the beginning of the
earliest period presented.
[b] Merger expenses and exit costs of $8 million and $30 million have
been eliminated from the results of operations for the three
months ended September 30, 2009 and 2008, respectively, and $473
million and $83 million for the nine months ended September 30,
2009 and 2008, respectively, as they represent nonrecurring
charges.
[c] Activity assessment fees and Section 31 fees have been excluded from
revenues and expenses, respectively, as they have no impact on
operating income or net income.
[d] Excludes $36 million of income from the reversal of an accrual
relating to certain litigation between a former Chairman & CEO and
the NYSE, which was terminated on July 31, 2008.
[e] Corporate Items include intercompany eliminations of revenues and
expenses between U.S. and Europe.
NYSE Euronext
Reconciliation of non-GAAP financial measures to GAAP measures
(unaudited)
(in millions)
We use non-GAAP financial measures of operating performance.
Non-GAAP measures do not replace and are not superior to the
presentation of
our GAAP financial results but are provided to
improve overall understanding of our current financial performance
and our prospects for the future.
Three months ended September 30, U.S. GAAP Pro Forma Pro Forma
2009 Results Adjustments Combined
Revenues $ 1,163 $ (115 ) [a] $ 1,048
Operating expenses, net (974 ) 123 [b] (851 )
Operating income 189 8 197
Net interest and investment loss (28 ) - (28 )
Other income 10 (4 ) [c] 6
Income before income tax provision 171 4 175
Income tax provision (47 ) 9 [d] (38 )
Net income 124 13 137
Noncontrolling interest 1 - 1
Net income attributable to NYSE Euronext $ 125 $ 13 $ 138
Three months ended September 30, U.S. GAAP Pro Forma Pro Forma
2008 Results Adjustments Combined
Revenues $ 1,205 $ (46 ) [a] $ 1,159
Operating expenses, net (938 ) 76 [b] (862 )
Operating income 267 30 297
Net interest and investment loss (31 ) - (31 )
Other income 5 - 5
Income before income tax provision 241 30 271
Income tax provision (70 ) (9 ) [d] (79 )
Income from discontinued operations, net of tax 3 (3 ) [e] -
Net income 174 18 192
Noncontrolling interest - - -
Net income attributable to NYSE Euronext $ 174 $ 18 $ 192
Nine months ended September 30, 2009 U.S. GAAP Pro Forma Pro Forma
Results Adjustments Combined
Revenues $ 3,556 $ (271 ) [a] $ 3,285
Operating expenses, net (3,436 ) 744 [b] (2,692 )
Operating income 120 473 593
Net interest and investment loss (81 ) - (81 )
Other income 19 (4 ) [c] 15
Income before income tax provision 58 469 527
Income tax provision (7 ) (134 ) [d] (141 )
Net income 51 335 386
Noncontrolling interest (4 ) - (4 )
Net income attributable to NYSE Euronext $ 47 $ 335 $ 382
Nine months ended September 30, 2008 U.S. GAAP Pro Forma Pro Forma
Results Adjustments Combined
Revenues $ 3,486 $ (189 ) [a] $ 3,297
Operating expenses, net (2,600 ) 236 [b] (2,364 )
Operating income 886 47 933
Net interest and investment loss (72 ) - (72 )
Gain on sale of businesses and equity investment 2 (2 ) -
Other income 28 - 28
Income before income tax provision 844 45 889
Income tax provision (244 ) (14 ) [d] (258 )
Income from discontinued operations, net of tax 5 (5 ) [e] -
Net income 605 26 631
Noncontrolling interest (5 ) - (5 )
Net income attributable to NYSE Euronext $ 600 $ 26 $ 626
[a] Includes Activity assessment fees.
[b] Includes the following adjustments:
Three months ended Nine months ended
September30, 2009 September30, 2008 September30, 2009 September30, 2008
Section 31 fees $ 115 $ 46 $ 271 $ 189
Merger expenses and exit costs 8 30 473 83
Compensation - - - (36 )*
$ 123 $ 76 $ 744 $ 236
* To eliminate the reversal of an accrual relating to
certain litigation.
[c] Includes a $4 million net gain from the sale of our investment in
BM&F Bovespa, partially offset by fair value adjustments of our
investments in Hugin, an asset-held-for-sale, and BIDS Holdings,
L.P.
[d] Includes the tax effect of pro forma adjustments and normalization
of our effective tax rate.
[e] Includes the adjustment to present results of operations as if the
divestiture of GL Trade had been completed at the beginning of the
earliest period presented.
NYSE Euronext Operating expenses including non-GAAP financial measures (unaudited) (in millions) We use non-GAAP financial measures of operating performance. Non-GAAP measures do not replace and are not superior to the presentation of our GAAP financial results but are provided to improve overall understanding of our current financial performance and our prospects for the future. Operating expenses for the three months ended September 30, 2009 $ 978 on a GAAP basis less: Section 31 fees (115 ) Liquidity payments (363 ) Routing and clearing (61 ) Merger expenses and exit costs (8 ) Fixed operating expenses for the three months ended September 30, 431 2009 Excluding the impact of: Currency translation 10 Acquisitions and dispositions, net (21 ) * New business initiatives (21 ) ** Duplicative datacenter and integration (2 ) Fixed operating expenses for the three months ended September 30, $ 397 [a] 2009 on a pro forma non-GAAP basis Operating expenses for the three months ended September 30, 2008 on $ 939 a GAAP basis less: Section 31 fees (46 ) Liquidity payments (358 ) Routing and clearing (77 ) Merger expenses and exit costs (30 ) Fixed operating expenses for the three months ended September 30, $ 428 [b] 2008 Variance ($) $ (31 ) [a] - [b] = [c] Variance (%) -7 % [c] / [b] Operating expenses for the nine months ended September 30, 2009 on a $ 3,441 GAAP basis less: Section 31 fees (271 ) Liquidity payments (1,242 ) Routing and clearing (204 ) Merger expenses and exit costs (473 ) Fixed operating expenses for the nine months ended September 30, 2009 1,251 Excluding the impact of: Currency translation 74 Acquisitions and dispositions, net (109 ) * New business initiatives (53 ) ** Duplicative datacenter and integration (15 ) Fixed operating expenses for the nine months ended September 30, $ 1,148 [d] 2009 on a pro forma non-GAAP basis Operating expenses for the nine months ended September 30, 2008 on a $ 2,639 *** GAAP basis less: Section 31 fees (189 ) Liquidity payments (887 ) Routing and clearing (211 ) Merger expenses and exit costs (83 ) Fixed operating expenses for the nine months ended September 30, 2008 $ 1,269 [e] Variance ($) $ (121 ) [d] - [e] = [f] Variance (%) -10 % [f] / [e]
* Includes the contribution of Amex and AEMS.
** Includes the contribution of new business initiatives, primarily
SFTI Europe, SmartPool, LiffeClear and NYSE Liffe U.S. (for the
nine-month period only).
*** Adjusted to exclude $36 million of income from the reversal of an
accrual related to certain litigation.
NYSE Euronext
Condensed consolidated statements of financial condition (unaudited)
(in millions)
September30, 2009 December31, 2008
Assets
Current assets:
Cash, cash equivalents, investment and other securities $ 497 $ 1,013
Accounts receivable, net 575 744
Deferred income taxes 90 113
Other current assets 275 156
Total current assets 1,437 2,026
Property and equipment, net 853 695
Goodwill 4,199 3,985
Other intangible assets, net 6,206 5,866
Deferred income taxes 664 671
Investment in associates and other assets 812 705
Total assets $ 14,171 $ 13,948
Liabilities and equity
Accounts payable and accrued expenses $ 1,058 $ 1,330
Deferred revenue 241 113
Short term debt 704 1,101
Deferred income taxes 26 38
Total current liabilities 2,029 2,582
Long term debt 2,197 1,787
Deferred income taxes 2,081 2,002
Accrued employee benefits 529 576
Deferred revenue 358 360
Other liabilities 177 67
Total liabilities 7,371 7,374
Equity 6,800 6,574
Total liabilities and equity $ 14,171 $ 13,948
NYSE Euronext
Selected
Statistical Data:
Volume Summary - Cash Products
Average Daily Volume Total Volume Total Volume
(Unaudited) Q3 '09 Q3 '08 % Chg Q3 '09 Q3 '08 % Chg YTD 2009 YTD 2008 % Chg
Number of Trading Days - European Markets 66 66 - 66 66 - 191 192 -
Number of Trading Days - U.S. Markets 64 64 64 64 188 188 -
European Cash Products (trades in thousands) 1,319 1,552 -15.0% 87,046 102,421 -15.0% 263,858 293,235 -10.0%
Equities 1,267 1,502 -15.6% 83,633 99,146 -15.6% 252,636 283,250 -10.8%
Exchange-Traded Funds 14 8 73.2% 911 526 73.2% 2,694 1,496 80.1%
Structured Products 32 37 -12.9% 2,135 2,451 -12.9% 7,459 7,489 -0.4%
Bonds 6 5 23.1% 367 298 23.1% 1,069 1,000 6.9%
U.S. Cash Products (shares in millions) 2,926 3,622 -19.2% 187,293 231,803 -19.2% 662,283 632,836 4.7%
NYSE Listed Issues (1)
NYSE Group Handled Volume (2) 2,165 2,659 -18.6% 138,569 170,167 -18.6% 482,915 469,306 2.9%
NYSE Group Matched Volume (3) 1,967 2,395 -17.9% 125,872 153,289 -17.9% 438,119 423,333 3.5%
Total NYSE Listed Consolidated Volume 5,546 5,633 -1.5% 354,934 360,498 -1.5% 1,127,225 905,642 24.5%
NYSE Group Share of Total NYSE Listed Consolidated Volume
Handled Volume (2) 39.0% 47.2% -8.2% 39.0% 47.2% -8.2% 42.8% 51.8% -9.0%
Matched Volume (3) 35.5% 42.5% -7.0% 35.5% 42.5% -7.0% 38.9% 46.7% -7.9%
NYSE Arca & Amex Listed Issues
NYSE Group Handled Volume (2) 407 508 -19.8% 26,053 32,495 -19.8% 106,095 77,835 36.3%
NYSE Group Matched Volume (3) 352 445 -20.9% 22,539 28,498 -20.9% 92,784 67,670 37.1%
Total NYSE Arca & Amex Listed Consolidated Volume 1,532 1,609 -4.8% 98,022 102,988 -4.8% 384,083 237,723 61.6%
NYSE Group Share of Total NYSE Arca & NYSE Amex Listed
Consolidated Volume
Handled Volume (2) 26.6% 31.6% -5.0% 26.6% 31.6% -5.0% 27.6% 32.7% -5.1%
Matched Volume (3) 23.0% 27.7% -4.7% 23.0% 27.7% -4.7% 24.2% 28.5% -4.3%
Nasdaq Listed Issues
NYSE Group Handled Volume (2) 354 455 -22.2% 22,671 29,141 -22.2% 73,273 85,696 -14.5%
NYSE Group Matched Volume (3) 284 387 -26.7% 18,146 24,747 -26.7% 59,832 71,772 -16.6%
Total Nasdaq Listed Consolidated Volume 2,252 2,261 -0.4% 144,121 144,705 -0.4% 432,146 428,240 0.9%
NYSE Group Share of Total Nasdaq Listed Consolidated Volume
Handled Volume (2) 15.7% 20.1% -4.4% 15.7% 20.1% -4.4% 17.0% 20.0% -3.1%
Matched Volume (3) 12.6% 17.1% -4.5% 12.6% 17.1% -4.5% 13.8% 16.8% -2.9%
Exchange-Traded Funds (1,4)
NYSE Group Handled Volume (2) 386 539 -28.4% 24,685 34,473 -28.4% 104,496 82,759 26.3%
NYSE Group Matched Volume (3) 335 474 -29.3% 21,453 30,338 -29.3% 91,621 72,391 26.6%
Total ETF Consolidated Volume 1,507 1,699 -11.3% 96,436 108,732 -11.3% 388,848 250,137 55.5%
NYSE Group Share of Total ETF Consolidated Volume
Handled Volume (2) 25.6% 31.7% -6.1% 25.6% 31.7% -6.1% 26.9% 33.1% -6.2%
Matched Volume (3) 22.2% 27.9% -5.7% 22.2% 27.9% -5.7% 23.6% 28.9% -5.4%
Please refer to footnotes on the following page.
NYSE Euronext
Selected
Statistical Data:
Volume Summary - Derivatives Products
(Unaudited; contracts in thousands) Average Daily Volume Total Volume Total Volume
Q3 '09 Q3 '08 % Chg Q3 '09 Q3 '08 % Chg YTD 2009 YTD 2008 % Chg
Number of Trading Days - European Markets 66 66 - 66 66 - 191 192 -
Number of Trading Days - U.S. Markets 64 64 64 64 188 189
European Derivatives Products 3,807 3,756 1.4% 251,265 247,864 1.4% 792,109 813,622 -2.6%
Total Interest Rate Products(5) 1,907 1,920 -0.7% 125,878 126,723 -0.7% 385,125 443,738 -13.2%
Short Term Interest Rate Products 1,809 1,816 -0.4% 119,412 119,855 -0.4% 366,212 423,361 -13.5%
Medium and Long Term Interest Rate Products 98 104 -5.9% 6,466 6,868 -5.9% 18,913 20,377 -7.2%
Total Equity Products (6) 1,853 1,786 3.8% 122,306 117,861 3.8% 397,997 359,465 10.7%
Total Individual Equity Products 1,272 1,116 14.0% 83,971 73,657 14.0% 280,130 234,432 19.5%
Total Equity Index Products 581 670 -13.3% 38,335 44,203 -13.3% 117,867 125,033 -5.7%
Bclear 853 637 34.1% 56,325 42,014 34.1% 204,565 145,208 40.9%
Individual Equity Products 729 519 40.6% 48,146 34,241 40.6% 179,381 124,880 43.6%
Equity Index Products 124 118 5.2% 8,179 7,773 5.2% 25,184 20,328 23.9%
Commodity Products 47 50 -6.1% 3,082 3,281 -6.1% 8,987 10,418 -13.7%
U.S. Derivatives Products - Equity Options (7)
NYSE Group Options Contracts 2,580 1,763 46.3% 165,099 112,836 46.3% 467,409 328,292 42.4%
Total Consolidated Options Contracts 13,227 14,388 -8.1% 846,525 920,824 -8.1% 2,543,548 2,521,133 0.9%
NYSE Group Share of Total 19.5% 12.3% 19.5% 12.3% 18.4% 13.0% 5.4%
NYSE Liffe U.S.
Futures and Futures Options Volume 14.8 - 949.9 - 3,113.5 - -
(1) Includes all volume executed in NYSE Group crossing sessions.
(2) Represents the total number of shares of equity securities and ETFs
internally matched on the NYSE Group's exchanges or routed to and
executed at an external market center. NYSE Arca routing includes
odd-lots.
(3) Represents the total number of shares of equity securities and ETFs
executed on the NYSE Group's exchanges.
(4) Data included in previously identified categories.
(5) Includes currency products.
(6) Includes all trading activities for Bclear, NYSE Liffe's clearing
service for wholesale derivatives.
(7) Includes trading in U.S. equity options contracts, not equity-index
options.
Source: NYSE Euronext, Options Clearing Corporation and Consolidated
Tape as reported for equity securities.
All trading activity is single-counted, except European cash trading
which is double counted to include both buys and sells.
US data has been updated for Amex integration for October 2008
forward.
NYSE Euronext
Selected
Statistical Data:
Other Operating Statistics
Three Months Ended
(Unaudited) September30, 2009 June30, 2009 September30, 2008
NYSE Euronext Listed Issuers
NYSE Listed Issuers
Issuers listed on U.S. Markets(1) 2,974 2,988 2,494
Number of new issuer listings(1) 61 73 66
Capital raised in connection with new listings ($millions)(2) $ 3,098 $ 1,445 $ 188
Euronext Listed Issuers
Issuers listed on Euronext(1) 1,040 1,046 1,126
Number of new issuer listings(3) 16 6 25
Capital raised in connection with new listings ($millions)(2) $ 7 $ 1 $ 392
NYSE Euronext Market Data
NYSE Market Data(4)
Share of Tape A revenues (%) 45.1 % 47.5 % 48.7 %
Share of Tape B revenues (%) 31.7 % 33.8 % 31.3 %
Share of Tape C revenues (%) 19.0 % 19.6 % 20.6 %
Professional subscribers (Tape A) 388,468 403,588 447,627
Euronext Market Data
Number of terminals 240,007 250,176 278,029
NYSE Euronext Operating Expenses
NYSE Euronext employee headcount(5)
NYSE Euronext headcount excluding GL Trade 3,399 3,538 3,505
GL Trade headcount n.a. n.a. 1,461
NYSE Euronext Financial Statistics
NYSE Euronext foreign exchange rate
Average EUR /US$ exchange rate $ 1.430 $ 1.364 $ 1.503
Average GBP /US$ exchange rate $ 1.641 $ 1.551 $ 1.893
(1) Figures for NYSE listed issuers include listed operating companies,
SPACs, closed-end funds, and ETFs, and do not include NYSE Arca,
Inc. or structured products listed on the NYSE. There were 1,034
ETFs and 4 operating companies exclusively listed on NYSE Arca, Inc.
as of September 30, 2009. There were 476 structured products listed
on the NYSE as of September 30, 2009.
Figures for new issuer listings include NYSE new listings and new
ETP listings only (NYSE Amex and NYSE Arca are excluded). Figures
for Euronext present the operating companies were listed on
Euronext and do not include NYSE Alternext, Free Market, closed
funds, ETFs and structured product (warrants and certificates). As
of September 30, 2009, 125 companies were listed on NYSE
Alternext, 311 on Free Market and 480 ETFs were listed on
NextTrack.
(2) Euronext figures show capital raised in millions of dollars by
operating companies listed on Euronext, NYSE Alternext and Free
Market and do not include closed-end funds, ETFs and structured
products (warrants and certificates). NYSE figures show capital
raised in millions of dollars by operating companies listed on NYSE
and NYSE Arca and do not include closed-end funds, ETFs and
structured products.
(3) Euronext figures include operating companies listed on Euronext,
NYSE Alternext and Free Market and do not include closed-end funds,
ETFs and structured products (warrants and certificates).
(4) "Tape A" represents NYSE listed securities, "Tape B" represents NYSE
Arca and NYSE Amex listed securities, and "Tape C" represents Nasdaq
listed securities. Per Regulation NMS, as of April 1, 2007, share of
revenues is derived through a formula based on 25% share of trading,
25% share of value traded, and 50% share of quoting, as reported to
the consolidated tape. Prior to April 1, 2007, share of revenues for
Tape A and B was derived based on number of trades reported to the
consolidated tape, and share of revenue for Tape C was derived based
on an average of share of trades and share of volume reported to the
consolidated tape. The consolidated tape refers to the collection
and dissemination of market data that multiple markets make
available on a consolidated basis. Share figures exclude
transactions reported to the FINRA/NYSE Trade Reporting Facility.
(5) NYSE Euronext sold its 40% stake in GL Trade in October 2008. NYSE
Euronext headcount includes both the employees of NYXT and NYSE Amex
for all periods presented.
Source: NYSE Euronext, Options Clearing Corporation and Consolidated
Tape as reported for equity securities.
SOURCE: NYSE Euronext
NYSE Euronext Media: +31.20.550.4488 (Amsterdam) +32.2.509.1392 (Brussels) +351.217.900.029 (Lisbon) +44.20.7379.2789 (London) +1.212.656.2140 (New York) +33.1.49.27.11.33 (Paris) or Investor Relations: +1.212.656.5700 (New York) +33.1.49.27.58.60 (Paris)
Tags: acquisition africa amex annual report asia bandwidth banking bonds brazil business capitalization ceo commercial commodity communications community conference corporate currency dealer debt dollar earnings eps equity europe exchange traded fund financial results foreign exchange futures gaap government index investment ipo joint venture licenses liffe london market market share marketing media medical merger mergers and acquisitions nasdaq networking new_york note nyse otc paris partnership president products property public offering rates restructuring revenue sales sec securities software tax taxes technology telecommunications tokyo trade united states us dollar wholesale
Companies: NYSE Group Inc (NYX)
NYSE Euronext Announces Trading Volumes for August 2009 - Zibb.com
NEW YORK, Sep 04, 2009 (BUSINESS WIRE) --
NYSE Euronext (NYX) today announced trading volumes for its global cash equities and derivatives exchanges for August 2009(1). Trading volumes in August generally rebounded from July levels resulting in year-over-year increases across all trading venues with European cash and derivatives volume up 5.3% and 15.9%, respectively, and U.S. cash and derivatives volume up 6.4% and 66.9%, respectively.
Highlights
-- NYSE, NYSE Arca and NYSE Amex ("NYSE Group") U.S. cash products handled ADV in August 2009 increased 6.4% and 3.9% compared to August 2008 and July 2009, respectively, and increased 11.3% year-to-date. NYSE Group matched share of all U.S. equity trading volume in August 2009 was 27.3%, compared to matched market share of 21.1% for our next largest competitor.
-- NYSE Euronext is the largest exchange operator in the two fastest growing tapes in the U.S. equity markets. Year-to-date, total Tape A and Tape B consolidated ADV increased a combined 43.2%, compared to the prior year period, while Tape C consolidated ADV has increased only 2.3% during the same period.
-- NYSE Euronext European cash products ADV of 1.3 million transactions in August 2009 increased 5.3% and 10.1% compared to August 2008 and July 2009, respectively. Year-to-date transactions of 1.4 million were 7.8% below the same period last year.
-- NYSE Euronext European derivatives products ADV in August 2009 was 3.5 million contracts, up 15.9% from August 2008, and down 1.7% from July 2009. Total interest rate products ADV was 1.9 million contracts, up 12.0% compared to August 2008 and total equity products ADV of 1.6 million contracts increased 21.8% from 1.3 million contracts.
-- NYSE Euronext U.S. equity options ADV of 2.3 million contracts in August 2009 increased 66.9% compared to August 2008 levels, but decreased 5.5% from July 2009. The increase in ADV year-over-year was driven mostly by the addition of the former Amex options business.
(1) Euronext equities transactions count each buy and sell order as separate transactions, NYSE Group equities transactions count buy and sell orders together as a single transaction. All NYSE Euronext derivatives transactions count buy and sell orders together as a single transaction. Prior year period does not include the former Amex equities and options businesses.
Cash Trading
U.S. Cash
NYSE Group U.S. cash products handled ADV in August 2009 increased 6.4% to 2.9 billion shares, compared to August 2008 and increased 3.9% from July 2009. Year-to-date, NYSE Group handled ADV of 3.6 billion shares was 11.3% above the same period last year. NYSE Group matched share of all U.S. equity volume in August 2009 was 27.3%, compared to matched market share of 21.1% for our next largest competitor. Consolidated Tape A and Tape B trading volume in August accounted for approximately 77% of all Consolidated Tape trading in the U.S. market which includes trade reporting facility ("TRF") volumes.
NYSE-listed (Tape A)
-- Total Tape A consolidated ADV in August 2009 increased 35.7% to 5.9 billion shares compared to 4.3 billion shares in August 2008 and increased 15.9% compared to July 2009. Year-to-date, total Tape A consolidated ADV of 6.0 billion shares was 32.9% above the prior year period.
-- Tape A matched ADV of NYSE Group in August 2009 increased 9.3% to 2.0 billion shares compared to August 2008 and 6.8% compared to July 2009. Year-to-date, NYSE Group matched ADV in Tape A increased 9.5% compared to the prior year period.
-- NYSE Group's Tape A matched market share in August 2009 was 33.8%, down from 36.6% in July 2009, and compared to matched market share of 16.5% for our next largest competitor. The decline in market share in August 2009 was driven in part by a significant increase in TRF executed volume in the top-10 most actively traded stocks which represented approximately 39% of Tape A consolidated activity, up from approximately 26% in July 2009. Excluding the impact of the volume of the top-10 most actively traded stocks, Tape A matched market share would have been 39.4% in July and 39.1% in August. Largely as a result of the activity in these top-10 stocks, TRF market share across Tape A increased 370 basis points in August 2009 to 37.6% and up from 25.0% in December 2008.
-- Designated Market Maker ("DMM") participation in August 2009 was 8.8%, compared to 8.7% in July 2009. Supplemental Liquidity Provider ("SLP") participation in August 2009 was 7.6%, compared to 7.7% in July 2009. DMM and SLP participation pertain only to trading on NYSE.
NYSE Arca and NYSE Amex-listed (Tape B)
-- Total Tape B consolidated ADV in August 2009 increased 25.1% to 1.5 billion shares compared to August 2008 and decreased 3.8% compared to July 2009. Year-to-date, total Tape B consolidated ADV of 2.1 billion shares was 81.5% above the prior year period.
-- NYSE Group's matched ADV of Tape B in August 2009 increased 11.5% to 349 million shares compared to August 2008 and declined 2.8% compared to July 2009. Year-to-date, NYSE Group Tape B matched ADV was 55.3% above the prior year period.
-- Tape B matched market share of NYSE Group in July 2009 was 23.3%, up from 23.1% in July 2009, compared to matched market share of 24.2% for our next largest competitor. TRF market share across Tape B increased in August 2009 to 34.8% from 21.5% in December 2008.
Nasdaq-listed (Tape C)
-- Total Tape C consolidated ADV in August 2009 increased 13.5% to 2.2 billion shares, compared to 1.9 billion shares in August 2008. Tape C consolidated volumes represented approximately 23% of all Consolidated Tape trading in the U.S. in August 2009. Year-to-date, total Tape C consolidated ADV was 2.3% above the prior year period.
-- NYSE Group's matched ADV of Tape C decreased 14.7% to 271 million shares in August 2009 compared to 318 million shares in August 2008 and decreased 4.9% compared to July 2009. Year-to-date, NYSE Group's Tape C matched ADV decreased 13.6% to 321 million shares.
-- NYSE Group's Tape C matched market share decreased to 12.6% from 12.9% in August 2009, compared to matched market share of 31.8% for our nearest competitor, down from 33.1% in July. TRF market share across Tape C increased in August 2009 to 40.2% from 29.9% in December 2008.
Exchange Traded Products
-- NYSE Group matched exchange-traded products ADV (included in volumes from Tape B and Tape C noted above) was flat in August 2009 compared to the prior year period at 332 million shares. Year-to-date, matched exchange-traded products ADV was 44.1% above the prior year period.
European Cash
NYSE Euronext European cash products ADV of 1.3 million transactions in August 2009 increased 5.3%, compared to August 2008 and increased 10.1% compared to July 2009. Year-to-date, European cash products ADV of 1.4 million transactions was 7.8% below the same period last year.
Derivatives Trading
European Derivatives
NYSE Euronext European derivatives products ADV in August 2009 was 3.5 million futures and options contracts, an increase of 15.9% from August 2008, but down 1.7% from the 3.6 million contracts recorded in July 2009. The 3.5 million in futures and options contracts ADV in August 2009 consisted of 2.8 million contracts executed through our full-service LIFFE CONNECT trading platform and a total of 0.6 million, or 18.4%, of the contracts executed through Bclear, NYSE Liffe's trade administration and clearing service for OTC products. Year-to-date European derivatives products ADV of 4.1 million contracts was 1.1% below prior year levels.
-- Total interest rate products ADV increased 12.0% to 1.9 million contracts from 1.7 million contracts in August 2008 and increased 17.9% from July 2009. Year-to-date, total interest rate products ADV decreased 14.4% compared to the prior year period.
-- Total equity products (including Bclear) ADV increased 21.8% to 1.6 million contracts from August 2008 and decreased 17.7% compared to July 2009. Total equity products ADV in August executed through our full-service LIFFE CONNECT trading platform was 0.9 million contracts, in-line with the prior year period. Year-to-date total equity products ADV increased 16.6% above the prior year period.
U.S. Derivatives
NYSE Euronext's U.S. equity options (NYSE Arca and NYSE Amex) ADV in August 2009 increased 66.9% to 2.3 million contracts compared to August 2008, but decreased 5.8% compared to July 2009. Total U.S. consolidated options ADV increased 10.5% to 12.7 million contracts in August 2009, and decreased 2.1% from July 2009. Year-to-date, U.S. equity options volume of 2.4 million contracts was 42.2% above the prior year period. NYSE Euronext's U.S. options exchanges accounted for 18.2% of the total consolidated equity options trading in August 2009, up from 12.0% in August 2008, but down from the 18.8% in July 2009.
Please click here for the Monthly Transaction Activity Data Table.
About NYSE Euronext
NYSE Euronext (NYX) is a leading global operator of financial markets and provider of innovative trading technologies. The company's exchanges in Europe and the United States trade equities, futures, options, fixed-income and exchange-traded products. With more than 8,000 listed issues, NYSE Euronext's equities markets -- the New York Stock Exchange, Euronext, NYSE Arca and NYSE Amex -- represent nearly 40 percent of the world's equities trading, the most liquidity of any global exchange group. NYSE Euronext also operates NYSE Liffe, the leading European derivatives business and the world's second-largest derivatives business by value of trading. The company offers comprehensive commercial technology, connectivity and market data products and services through NYSE Technologies. NYSE Euronext is in the S&P 500 index, and is the only exchange operator in the S&P 100 index and Fortune 500. For more information, please visit: www.nyx.com
Cautionary Note Regarding Forward-Looking Statements
This press release may contain forward-looking statements, including forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements include, but are not limited to, statements concerning NYSE Euronext's plans, objectives, expectations and intentions and other statements that are not historical or current facts. Forward-looking statements are based on NYSE Euronext's current expectations and involve risks and uncertainties that could cause actual results to differ materially from those expressed or implied in such forward-looking statements. Factors that could cause NYSE Euronext's results to differ materially from current expectations include, but are not limited to: NYSE Euronext's ability to implement its strategic initiatives, economic, political and market conditions and fluctuations, government and industry regulation, interest rate risk and U.S. and global competition, and other factors detailed in NYSE Euronext's reference document for 2008 ("document de reference") filed with the French Autorite des Marches Financiers (Registered on April 28, 2009 under No. R. 09-031), 2008 Annual Report on Form 10-K and other periodic reports filed with the U.S. Securities and Exchange Commission or the French Autorite des Marches Financiers. In addition, these statements are based on a number of assumptions that are subject to change. Accordingly, actual results may be materially higher or lower than those projected. The inclusion of such projections herein should not be regarded as a representation by NYSE Euronext that the projections will prove to be correct. This press release speaks only as of this date. NYSE Euronext disclaims any duty to update the information herein.
NYSE Euronext
Monthly Volume Summary - Cash
Products
Average Daily Volume Total Volume Average Daily Volume Total Volume
(Unaudited) Aug-09 Aug-08 % Chg Aug-09 Aug-08 % Chg YTD 2009 % Chg vs. YTD 2009 % Chg vs.
YTD 2008 YTD 2008
Number of Trading Days - European Markets 21 21 21 21 169 169
Number of Trading Days - U.S. Markets 21 21 21 21 167 167
European Cash Products (trades in thousands) 1,303 1,238 5.3% 27,364 25,990 5.3% 1,369 -7.8% 231,415 -8.4%
Equities 1,252 1,198 4.5% 26,283 25,148 4.5% 1,310 -8.7% 221,395 -9.2%
Exchange-Traded Funds 14 5 162.9% 290 110 162.9% 14 89.9% 2,385 88.7%
Structured Products 32 31 3.9% 679 654 3.9% 40 3.9% 6,697 3.2%
Bonds 5 4 44.6% 112 77 44.6% 6 5.9% 938 5.3%
U.S. Cash Products (shares in millions)( 2) 2,937 2,760 6.4% 61,679 57,965 6.4% 3,586 11.3% 598,838 10.7%
NYSE Listed (Tape A) Issues (1)
NYSE Group Handled Volume (2) 2,199 2,021 8.8% 46,176 42,443 8.8% 2,609 8.9% 435,677 8.2%
NYSE Group Matched Volume (3) 1,989 1,819 9.3% 41,779 38,208 9.3% 2,365 9.5% 394,987 8.8%
Total NYSE Listed Consolidated Volume 5,890 4,342 35.7% 123,696 91,180 35.7% 6,035 32.9% 1,007,811 32.2%
NYSE Group Share of Total Consolidated Volume
Handled Volume (2) 37.3% 46.5% -9.2% 37.3% 46.5% -9.2% 43.2% -9.6% 43.2% -9.6%
Matched Volume (3) 33.8% 41.9% -8.1% 33.8% 41.9% -8.1% 39.2% -8.4% 39.2% -8.4%
NYSE Arca & Amex (Tape B) Listed Issues
NYSE Group Handled Volume (2) 403 362 11.4% 8,459 7,595 11.4% 585 54.0% 97,648 53.1%
NYSE Group Matched Volume (3) 349 313 11.5% 7,326 6,570 11.5% 512 55.3% 85,476 54.4%
Total NYSE Arca & Amex Listed Consolidated Volume 1,497 1,196 25.1% 31,441 25,126 25.1% 2,106 81.5% 351,727 80.4%
NYSE Group Share of Total Consolidated Volume
Handled Volume (2) 26.9% 30.2% -3.3% 26.9% 30.2% -3.3% 27.8% -4.9% 27.8% -4.9%
Matched Volume (3) 23.3% 26.1% -2.8% 23.3% 26.1% -2.8% 24.3% -4.1% 24.3% -4.1%
Nasdaq Listed (Tape C) Issues
NYSE Group Handled Volume (2) 335 377 -11.1% 7,044 7,926 -11.1% 392 -11.9% 65,513 -12.5%
NYSE Group Matched Volume (3) 271 318 -14.7% 5,695 6,674 -14.7% 321 -13.6% 53,641 -14.1%
Total Nasdaq Listed Consolidated Volume 2,150 1,893 13.5% 45,144 39,758 13.5% 2,285 2.3% 381,518 1.7%
NYSE Group Share of Total Consolidated Volume
Handled Volume (2) 15.6% 19.9% -4.3% 15.6% 19.9% -4.3% 17.2% -2.8% 17.2% -2.8%
Matched Volume (3) 12.6% 16.8% -4.2% 12.6% 16.8% -4.2% 14.1% -2.6% 14.1% -2.6%
Exchange-Traded Funds (1,4)
NYSE Group Handled Volume (2) 381 381 -0.1% 8,002 8,006 -0.1% 580 43.5% 96,858 42.7%
NYSE Group Matched Volume (3) 332 332 0.0% 6,974 6,973 0.0% 509 44.1% 84,965 43.2%
Total ETF Consolidated Volume 1,469 1,245 18.0% 30,855 26,141 18.0% 2,145 76.2% 358,169 75.1%
NYSE Group Share of Total Consolidated Volume
Handled Volume (2) 25.9% 30.6% -4.7% 25.9% 30.6% -4.7% 27.0% -6.2% 27.0% -6.2%
Matched Volume (3) 22.6% 26.7% -4.1% 22.6% 26.7% -4.1% 23.7% -5.3% 23.7% -5.3%
NYSE Euronext
Monthly Volume Summary -
Derivatives Products
Average Daily Volume Total Volume Average Daily Volume Total Volume
(Unaudited; contracts in thousands) Aug-09 Aug-08 % Chg Aug-09 Aug-08 % Chg YTD 2009 % Chg vs. YTD 2009 % Chg vs.
YTD 2008 YTD 2008
Number of Trading Days - European Markets 21 21 21 21 169 169
Number of Trading Days - U.S. Markets 21 21 21 21 167 167
European Derivatives Products 3,501 3,022 15.9% 73,525 63,453 15.9% 4,120 -1.1% 696,292 -1.7%
of which Bclear 643 412 56.3% 13,513 8,647 56.3% 1,101 51.7% 186,033 50.8%
Total Interest Rate Products 1,868 1,668 12.0% 39,233 35,030 12.0% 1,982 -14.4% 334,914 -14.9%
Short Term Interest Rate Products 1,758 1,547 13.6% 36,923 32,491 13.6% 1,883 -14.8% 318,206 -15.3%
Medium and Long Term Interest Rate Products( 5) 110 121 -9.0% 2,310 2,539 -9.0% 99 -6.6% 16,709 -7.1%
Total Credit Derivatives Products (Bclear) - - - - - -
Total Equity Products (6) 1,590 1,305 21.8% 33,389 27,413 21.8% 2,092 16.6% 353,535 15.9%
Individual Equity Products 1,041 794 31.1% 21,868 16,679 31.1% 1,482 26.6% 250,430 25.9%
Equity Index Products 549 511 7.3% 11,521 10,734 7.3% 610 -2.2% 103,105 -2.8%
of which Bclear 643 412 56.3% 13,513 8,647 56.3% 1,101 51.7% 186,033 50.8%
Individual Equity Products 534 308 73.2% 11,214 6,474 73.2% 972 55.9% 164,269 55.0%
Equity Index Products 109 103 5.8% 2,299 2,173 5.8% 129 26.4% 21,765 25.7%
Commodity Products 43 48 -10.7% 902 1,011 -10.7% 46 -15.3% 7,842 -15.8%
of which Bclear - - - - - -
U.S. Derivatives Products
U.S. Derivatives Products - Equity Options (7)
NYSE Group Options Contracts 2,307 1,382 66.9% 48,448 29,026 66.9% 2,422 42.2% 404,461 41.3%
Total Consolidated Options Contracts 12,710 11,504 10.5% 266,913 241,579 10.5% 13,471 3.8% 2,249,685 3.2%
NYSE Group Share of Total 18.2% 12.0% 18.2% 12.0% 18.0% 4.9% 18.0% 4.9%
NYSE Liffe U.S.
Precious Metals Futures Volume 12.2 - 255.4 - 16.0 - 2,674.9 -
(1) Includes all volume executed in NYSE Group crossing sessions.
(2) Represents the total number of shares of equity securities and ETFs
internally matched on the NYSE Group's exchanges or routed to and
executed at an external market center. NYSE Arca routing includes
odd-lots.
(3) Represents the total number of shares of equity securities and ETFs
executed on the NYSE Group's exchanges.
(4) Data included in previously identified categories.
(5) Data includes currency products.
(6) Includes all trading activities for Bclear, NYSE Liffe's clearing
service for wholesale derivatives.
(7) Includes trading in U.S. equity options contracts, not equity-index
options.
Source: NYSE Euronext, Options Clearing Corporation and Consolidated
Tape as reported for equity securities.
All trading activity is single-counted, except European cash trading
which is double counted to include both buys and sells.
US Equities data has been updated for Amex integration for October
2008 forward.
SOURCE: NYSE Euronext
NYSE Euronext Investor Relations: +1.212.656.5700 (New York) +33.1.49.27.58.60 (Paris) or Media: +31.20.550.4488 (Amsterdam), +32.2.509.1392 (Brussels) +351.217.900.029 (Lisbon), +44.20.7379.2789 (London) +1.212.656.2411 (New York), +33.1.49.27.11.33 (Paris)
Tags: amex annual report bonds business commercial commodity currency equity europe exchange traded fund futures government index liffe market market share metals nasdaq note nyse otc products securities technology trade wholesale
Companies: NYSE Group Inc (NYX)
Web Sites
Total : 44 View more »
RAD News - RITE AID CORPORATION news, press releases and podcasts on ...
finance.boston.com
Find financial news, press releases and podcasts for RITE AID CORPORATION (RAD) on Boston.com
http://finance.boston.com/boston?Page=News&Ticker=RAD&ChannelType=PODCAST
The prospect of NYSE Group merging with Euronext to create the world's first transatlantic exchange...
The prospect of NYSE Group merging with Euronext to create the world's first transatlantic exchange opens the gateway to trading multiple asset classes across national borders and regulatory frameworks on a single, global cash and derivatives trading platform.
http://www.banktech.com/printableArticle.jhtml?articleID=191801377
Announcement Related to NYSE Group-Euronext Combination
Announcement Related to NYSE Group-Euronext Combination New York and Paris, Nov. 21, 2006 -- Within the framework of the proposed merger, NYSE Group, Inc. (NYSE: NYX) and Euronext N.V.
Vivendi - Vivendi Universal has Already Obtained Approval to Amend the Deposit Agreement for
Owners of ADRs who gave their approval by April 14, 2006 are entitled to receive the consent payment of $0.10 per ADS and payments are expected to be made beginning on May 4, 2006.
http://www.vivendi.com/vivendi/Vivendi-Universal-has-Already
Web Sites
powered by 
Total : 14 View more »
NYSE Group Incorporated Company Details
www.zibb.com
NYSE, New York Stock Exchange > About Us > News & Events > News Releases > Press Release 09-04-2009 www.nyse.com. cash products handled ADV in August 2009 increased 6.4% and 3.9 ...
Goldman Sachs Financial Services CEO Conference
cc.talkpoint.com
NYSE Group, Incorporated: John Thain Chief Executive Officer U.S. Bancorp: Richard Davis President and CEO Wachovia Corporation: Ken Thompson Chairman, President & CEO
http://cc.talkpoint.com/GOLD006/121206a_kk/agenda.asp?day=Wednesday
N.Y.S.E. Will Close a Trading Floor Room - New York Times
www.nytimes.com
The New York Stock Exchange plans to close one of the five rooms on its ... The New York Stock Exchange; NYSE Group Incorporated; Manhattan (NYC)
Big Board Bids for Exchanges Across Europe - New York Times
www.nytimes.com
Traders were busy at the Euronext office in Paris Monday. Euronext also has ... NYSE Group Incorporated; Euronext Stock Exchange; Mergers, Acquisitions and Divestitures